Antiperspirant Cream Patent Application by Lume Deodorant LLC
Summary
The USPTO published patent application US20260090961A1 by Lume Deodorant, LLC for an antiperspirant cream composition containing water, an antiperspirant material, alpha-hydroxycarboxylic acid, an oil agent, and a structuring agent, with optional caffeine or xanthine derivatives. The application was filed on September 27, 2024, and names inventors Shannon Klingman, Stephanie Richmond, Rebecca Reynandez, and Nikita Bhatnagar. This is an informational publication of a patent application; no regulatory compliance obligations are created.
What changed
The USPTO published patent application US20260090961A1 for an antiperspirant cream composition by Lume Deodorant, LLC. The composition includes water, an antiperspirant material, alpha-hydroxycarboxylic acid, an oil agent, a structuring agent, and optionally caffeine or xanthine derivatives with vasoconstrictive effects. The application covers use on external skin areas including axilla, pudendum, feet, chest, abdomen, thigh, and buttock for odor and perspiration control. Application No. 18900122 was filed on September 27, 2024, with inventors Shannon Klingman, Stephanie Richmond, Rebecca Reynandez, and Nikita Bhatnagar.
This publication does not create any compliance obligations, deadlines, or penalties. It is informational only—competitors in the personal care and antiperspirant market should review the disclosed composition claims for potential freedom-to-operate implications. Patent prosecution typically takes several years before any patent rights are granted or enforced.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTIPERSPIRANT CREAM
Application US20260090961A1 Kind: A1 Apr 02, 2026
Assignee
Lume Deodorant, LLC
Inventors
Shannon Klingman, Stephanie Richmond, Rebecca Reynandez, Nikita Bhatnagar
Abstract
The present disclosure relates to antiperspirant cream composition that contains water, an antiperspirant material, an alpha-hydroxycarboxylic acid, an oil agent, a structuring agent and optionally caffeine or a xanthine derivative that has vasoconstrictive effects. The antiperspirant cream composition may be applied to a human's external skin in need or odor and perspiration control such as the user's axilla, pudendum, feet, chest, abdomen, thigh, and buttock.
CPC Classifications
A61K 8/0204 A61Q 15/00 A61K 2800/592 A61K 2800/805
Filing Date
2024-09-27
Application No.
18900122
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.